SCOPUS 정보 검색 플랫폼

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 2, 2009, Pages 354-360

Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006

(7) St Peter, Wendy L a,b Li, Qi a Liu, Jiannong a Persky, Martha c Nieman, Kimberly a Arko, Cheryl a Block, Geoffrey A c

a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION (United States)

b UNIVERSITY OF MINNESOTA (United States)

c Denver Nephrologists (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCITRIOL; CALCIUM; CALCIUM ACETATE; CALCIUM CARBONATE; CINACALCET; DOXERCALCIFEROL; LANTHANUM CARBONATE; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE BINDING AGENT; PHOSPHORUS; SEVELAMER; VITAMIN D; BIOLOGICAL MARKER; NAPHTHALENE DERIVATIVE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG UTILIZATION; FEMALE; HEALTH CARE ORGANIZATION; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOPARATHYROIDISM; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRESCRIPTION; SECONDARY HYPERPARATHYROIDISM; TREATMENT OUTCOME; ADOLESCENT; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL PRACTICE; DATA BASE; DRUG COMBINATION; DRUG USE; GOVERNMENT; MIDDLE AGED; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY; STATISTICS; TIME; UNITED STATES;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CALCIUM; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); DATABASES AS TOPIC; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NAPHTHALENES; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PARATHYROID HORMONE; PHOSPHORUS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VITAMIN D; YOUNG ADULT;

EID: 66849128215 PISSN: 15559041 EISSN: 1555905X Source Type: Journal
DOI: 10.2215/CJN.05241008 Document Type: Article

Times cited : (58)

References (8)

1
- 83055172414
- K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
- National Kidney Foundation
- National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42[Suppl 3]: S1-201, 2003
- (2003) Am J Kidney Dis , vol.42 , Issue.SUPPL. 3

2
- 11144353767
- Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
- DOI 10.1056/NEJMoa031633
- Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350: 1516-1525, 2004 (Pubitemid 38477776)
- (2004) New England Journal of Medicine , vol.350 , Issue.15 , pp. 1516-1525
- Block, G.A.¹ Martin, K.J.² De Francisco, A.L.M.³ Turner, S.A.⁴ Avram, M.M.⁵ Suranyi, M.G.⁶ Hercz, G.⁷ Cunningham, J.⁸ Abu-Alfa, A.K.⁹ Messa, P.¹⁰ Coyne, D.W.¹¹ Locatelli, F.¹² Cohen, R.M.¹³ Evenepoel, P.¹⁴ Moe, S.M.¹⁵ Fournier, A.¹⁶ Braun, J.¹⁷ McCary, L.C.¹⁸ Zani, V.J.¹⁹ Olson, K.A.²⁰ Drueke, T.B.²¹ Goodman, W.G.²² more..

3
- 20544460709
- Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study
- DOI 10.1681/ASN.2004060512
- Lindberg JS, Culleton B, Wong G, Borah MF, Clark RV, Shapiro W, Roger SD, Husserl FE, Klassen PS, Guo MD, Albizem MB, Coburn JW: Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study. J Am Soc Nephrol 16: 800-807, 2005 (Pubitemid 41725117)
- (2005) Journal of the American Society of Nephrology , vol.16 , Issue.3 , pp. 800-807
- Lindberg, J.S.¹ Culleton, B.² Wong, G.³ Borah, M.F.⁴ Clark, R.V.⁵ Shapiro, W.B.⁶ Roger, S.D.⁷ Husserl, F.E.⁸ Klassen, P.S.⁹ Guo, M.D.¹⁰ Albizem, M.B.¹¹ Coburn, J.W.¹²

4
- 19944430161
- Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl
- DOI 10.1111/j.1523-1755.2005.67139.x
- Moe SM, Chertow GM, Coburn JW, Quarles LD, Goodman WG, Block GA, Drueke TB, Cunningham J, Sherrard DJ, McCary LC, Olson KA, Turner SA, Martin KJ: Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 67: 760-771, 2005 (Pubitemid 40139871)
- (2005) Kidney International , vol.67 , Issue.2 , pp. 760-771
- Moe, S.M.¹ Chertow, G.M.² Coburn, J.W.³ Quarles, L.D.⁴ Goodman, W.G.⁵ Block, G.A.⁶ Drueke, T.B.⁷ Cunningham, J.⁸ Sherrard, D.J.⁹ McCary, L.C.¹⁰ Olson, K.A.¹¹ Turner, S.A.¹² Martin, K.J.¹³

5
- 27144515670
- Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl
- DOI 10.1093/ndt/gfh966
- Moe SM, Cunningham J, Bommer J, Adler S, Rosansky SJ, Urena-Torres P, Albizem MB, Guo MD, Zani VJ, Goodman WG, Sprague SM: Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant 20: 2186-2193, 2005 (Pubitemid 41510096)
- (2005) Nephrology Dialysis Transplantation , vol.20 , Issue.10 , pp. 2186-2193
- Moe, S.M.¹ Cunningham, J.² Bommer, J.³ Adler, S.⁴ Rosansky, S.J.⁵ Urena-Torres, P.⁶ Albizem, M.B.⁷ Guo, M.D.⁸ Zani, V.J.⁹ Goodman, W.G.¹⁰ Sprague, S.M.¹¹

6
- 34447281257
- Cinacalcet HC1 (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism
- Sterrett JR, Strom J, Stummvoll HK, Bahner U, Disney A, Soroka SD, Corpier C, Arruda JA, Schwanauer LE, Klassen PS, Olson KA, Block GA: Cinacalcet HCl (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism. Clin Nephrol 68: 10-17, 2007 (Pubitemid 47045487)
- (2007) Clinical Nephrology , vol.68 , Issue.1 , pp. 10-17
- Sterrett, J.R.¹ Strom, J.² Stummvoll, H.-K.³ Bahner, U.⁴ Disney, A.⁵ Soroka, S.D.⁶ Corpier, C.⁷ Arruda, J.A.⁸ Schwanauer, L.E.⁹ Klassen, P.S.¹⁰ Olson, K.A.¹¹ Block, G.A.¹²

7
- 72449158543
- Effects of intravenous active vitamin D dose and dosing regularity on mortality among hemodialysis patients
- in press
- St. Peter WL, Li S, Liu J, Gilbertson DT, Arneson TA, Collins AC: Effects of intravenous active vitamin D dose and dosing regularity on mortality among hemodialysis patients. Pharmacotherapy 2009, in press
- (2009) Pharmacotherapy
- St. Peter, W.L.¹ Li, S.² Liu, J.³ Gilbertson, D.T.⁴ Arneson, T.A.⁵ Collins, A.C.⁶

8
- 34548821615
- Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and design overview
- Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P: Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): Rationale and design overview. Clin J Am Soc Nephrol 2: 898-905, 2007
- (2007) Clin J Am Soc Nephrol , vol.2 , pp. 898-905
- Chertow, G.M.¹ Pupim, L.B.² Block, G.A.³ Correa-Rotter, R.⁴ Drueke, T.B.⁵ Floege, J.⁶ Goodman, W.G.⁷ London, G.M.⁸ Mahaffey, K.W.⁹ Moe, S.M.¹⁰ Wheeler, D.C.¹¹ Albizem, M.¹² Olson, K.¹³ Klassen, P.¹⁴ Parfrey, P.¹⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.